These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 9214455

  • 41. The antioxidant and antifibrogenic effects of the glycosaminoglycans hyaluronic acid and chondroitin-4-sulphate in a subchronic rat model of carbon tetrachloride-induced liver fibrogenesis.
    Campo GM, Avenoso A, Campo S, D'Ascola A, Ferlazzo AM, Calatroni A.
    Chem Biol Interact; 2004 Jul 20; 148(3):125-38. PubMed ID: 15276869
    [Abstract] [Full Text] [Related]

  • 42. Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
    Lee ES, Shin MO, Yoon S, Moon JO.
    Arch Pharm Res; 2010 Jun 20; 33(6):925-32. PubMed ID: 20607498
    [Abstract] [Full Text] [Related]

  • 43. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.
    Yasuda Y, Shimizu M, Sakai H, Iwasa J, Kubota M, Adachi S, Osawa Y, Tsurumi H, Hara Y, Moriwaki H.
    Chem Biol Interact; 2009 Dec 10; 182(2-3):159-64. PubMed ID: 19646978
    [Abstract] [Full Text] [Related]

  • 44. [Effect of cordyceps polysaccharide on lipid peroxidation of rats with dimethylnitrosamine-induced liver fibrosis].
    Peng JH, Li XM, Hu YY, Feng Q.
    Zhongguo Zhong Yao Za Zhi; 2013 Feb 10; 38(3):391-6. PubMed ID: 23668016
    [Abstract] [Full Text] [Related]

  • 45. The protective effect of cyclosporine against cirrhotic alteration of the liver.
    Lie TS, Preissinger H, Bach M, Vogel J, Ogawa K, Kroeger T, Brunner G.
    Surgery; 1991 Nov 10; 110(5):847-53. PubMed ID: 1948654
    [Abstract] [Full Text] [Related]

  • 46. Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride-induced chronic liver injury.
    Hagiwara S, Otsuka T, Yamazaki Y, Kosone T, Sohara N, Ichikawa T, Sato K, Kakizaki S, Takagi H, Mori M.
    Liver Int; 2008 Jan 10; 28(1):126-31. PubMed ID: 17976157
    [Abstract] [Full Text] [Related]

  • 47. Prevention of liver fibrosis and liver reconstitution of DMN-treated rat liver by transplanted EPCs.
    Nakamura T, Torimura T, Iwamoto H, Masuda H, Naitou M, Koga H, Abe M, Hashimoto O, Tsutsumi V, Ueno T, Sata M.
    Eur J Clin Invest; 2012 Jul 10; 42(7):717-28. PubMed ID: 22224757
    [Abstract] [Full Text] [Related]

  • 48. Recombinant bovine pancreatic trypsin inhibitor protects the liver from carbon tetrachloride-induced chronic injury in rats.
    Dong W, Lv B, Wei F, Yang L.
    Pharm Biol; 2013 Oct 10; 51(10):1298-303. PubMed ID: 23855331
    [Abstract] [Full Text] [Related]

  • 49. Vitamin A deficiency potentiates carbon tetrachloride-induced liver fibrosis in rats.
    Seifert WF, Bosma A, Brouwer A, Hendriks HF, Roholl PJ, van Leeuwen RE, van Thiel-de Ruiter GC, Seifert-Bock I, Knook DL.
    Hepatology; 1994 Jan 10; 19(1):193-201. PubMed ID: 8276355
    [Abstract] [Full Text] [Related]

  • 50. [Effect of gypenosides on DMN-induced liver fibrosis in rats].
    Feng Q, Li X, Peng J, Duan X, Fu Q, Hu Y.
    Zhongguo Zhong Yao Za Zhi; 2012 Feb 10; 37(4):505-8. PubMed ID: 22667153
    [Abstract] [Full Text] [Related]

  • 51. Antifibrotic effects of CGX, a traditional herbal formula, and its mechanisms in rats.
    Wang JH, Shin JW, Son JY, Cho JH, Son CG.
    J Ethnopharmacol; 2010 Feb 03; 127(2):534-42. PubMed ID: 19833189
    [Abstract] [Full Text] [Related]

  • 52. Matrix metalloproteinase-13 promotes recovery from experimental liver cirrhosis in rats.
    Endo H, Niioka M, Sugioka Y, Itoh J, Kameyama K, Okazaki I, Ala-Aho R, Kähäri VM, Watanabe T.
    Pathobiology; 2011 Feb 03; 78(5):239-52. PubMed ID: 21849805
    [Abstract] [Full Text] [Related]

  • 53. Carbon tetrachloride-induced hepatic fibrosis and cirrhosis in the developing rat: an experimental model of cirrhosis in childhood.
    Trivedi P, Mowat AP.
    Br J Exp Pathol; 1983 Feb 03; 64(1):25-33. PubMed ID: 6301521
    [Abstract] [Full Text] [Related]

  • 54. N-methyl-4-isoleucine cyclosporine attenuates CCl -induced liver fibrosis in rats by interacting with cyclophilin B and D.
    Wang H, Zhang Y, Wang T, You H, Jia J.
    J Gastroenterol Hepatol; 2011 Mar 03; 26(3):558-67. PubMed ID: 21332552
    [Abstract] [Full Text] [Related]

  • 55. Therapeutic effects of hepatocyte growth factor-overexpressing human umbilical cord blood-derived mesenchymal stem cells on liver fibrosis in rats.
    Seo KW, Sohn SY, Bhang DH, Nam MJ, Lee HW, Youn HY.
    Cell Biol Int; 2014 Jan 03; 38(1):106-16. PubMed ID: 24115681
    [Abstract] [Full Text] [Related]

  • 56. ED50 and recovery times after propofol in rats with graded cirrhosis.
    Li Z, Chen X, Meng J, Deng L, Ma H, Csete M, Xiong L.
    Anesth Analg; 2012 Jan 03; 114(1):117-21. PubMed ID: 22003221
    [Abstract] [Full Text] [Related]

  • 57. [A study on changes of liver and salivary glands in rats with experimentally induced liver injuries. Pathological and biochemical observations].
    Kishimoto Y.
    Shikwa Gakuho; 1990 Jun 03; 90(6):817-36. PubMed ID: 1725465
    [Abstract] [Full Text] [Related]

  • 58. [Development of liver cirrhosis in rats following stimulation of hepatic macrophages].
    Kutina SN, Maianskiĭ DN.
    Biull Eksp Biol Med; 1981 Sep 03; 92(9):366-9. PubMed ID: 7295995
    [Abstract] [Full Text] [Related]

  • 59. Immunolocalization of heparin-binding growth factors (HBGF) types 1 and 2 in rat liver. Selective hyperexpression of HBGF-2 in carbon tetrachloride-induced fibrosis.
    Charlotte F, Win KM, Preaux AM, Mavier P, Dhumeaux D, Zafrani ES, Rosenbaum J.
    J Pathol; 1993 Apr 03; 169(4):471-6. PubMed ID: 7684779
    [Abstract] [Full Text] [Related]

  • 60. [An experimental study on the protective effect of hepatocyte growth factor (HGF) for the primary cultured hepatocytes obtained from iron-loaded rats].
    Yoshida J.
    Hokkaido Igaku Zasshi; 1995 Jan 03; 70(1):99-111. PubMed ID: 7744374
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.